CD40 and laryngeal carcinoma: In attempting to understand why there are differences in CD40 genotypes but not in sCD40 levels, we believe that the impact of the CD40 (rs1883832) polymorphism on laryngeal cancer may be more closely tied to changes in the structure and function of the protein that is produced, rather than in the levels of gene products.